Search Results - "GIOVANELLA, BEPPINO"

Refine Results
  1. 1

    Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity by Dong, Dong, Hsiao, Cheng-Hui, Giovanella, Beppino C, Wang, Yifei, Chow, Diana Sl, Li, Zhijie

    Published in International journal of nanomedicine (01-05-2019)
    “…We have synthesized a novel lactone-stabilized camptothecin (CPT) analog named CZ48 and demonstrated its potent anticancer effects via bioconversion to the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    ISG15 as a novel tumor biomarker for drug sensitivity by Desai, Shyamal D, Wood, Laurence M, Tsai, Yu-Chen, Hsieh, Tao-Shih, Marks, Jeffrey R, Scott, Georgia L, Giovanella, Beppino C, Liu, Leroy F

    Published in Molecular cancer therapeutics (01-06-2008)
    “…Tumor cells are known to exhibit highly varied sensitivity to camptothecins (CPT; e.g., irinotecan and topotecan). However, the factors that determine CPT…”
    Get full text
    Journal Article
  5. 5

    Metabolic difference of CZ48 in human and mouse liver microsomes by Liu, Xing, Dejesus, Albert, Cao, Zhisong, Vardeman, Dana, Giovanella, Beppino

    “…CZ48, chemically camptothecin-20-O-propionate hydrate, is currently under clinical investigation. The kinetics of the metabolite camptothecin (CPT) formation…”
    Get full text
    Journal Article
  6. 6

    Enhanced lactone stability of CZ48 in blood correlates to its lack of toxicity in mice by Liu, Xing, Wang, Yang, Cao, Zhisong, Zhan, Max, Vardeman, Dana, Giovanella, Beppino

    “…The aim of this study was to correlate the relationship between the pharmacokinetic behaviors and the toxicity of a new investigational anticancer agent CZ48,…”
    Get full text
    Journal Article
  7. 7

    Desmoplastic small round cell tumor (DSRCT) xenografts and tissue culture lines: Establishment and initial characterization by MARKIDES, CONSTANTINE S.A, COIL, DOUGLAS R, LUONG, LINH H, MENDOZA, JOHN, KOZIELSKI, TONY, VARDEMAN, DANA, GIOVANELLA, BEPPINO C

    Published in Oncology letters (01-05-2013)
    “…Desmoplastic small round cell tumor (DSRCT) is an extremely rare and aggressive neoplasm, which mainly affects young males and generally presents as a widely…”
    Get full text
    Journal Article
  8. 8

    Anticancer activity of new haloalkyl camptothecin esters against human cancer cell lines and human tumor xenografts grown in nude mice by Cao, Zhisong, Mendoza, John, Kozielski, Anthony, Liu, Xing, Dejesus, Albert, Wang, Yang, Zhan, Chang-Guo, Vardeman, Dana, Giovanella, Beppino

    Published in Anti-cancer agents in medicinal chemistry (01-09-2012)
    “…All chemotherapeutic agents currently in use have a narrow window of therapeutic index of 1 to 1.2. Camptothecin ester compounds are reported to have a wider…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers by VERSCHRAEGEN, Claire F, WEI HU, GIOVANELLA, Beppino C, YU DU, MENDOZA, John, EARLY, Janet, DEAVERS, Michael, FREEDMAN, Ralph S, BAST, Robert C, KUDELKA, Andrzej P, KAVANAGH, John J

    Published in Clinical cancer research (01-02-2003)
    “…Purpose: The purpose of this study was to characterize cell cultures and xenografts derived from patients with ovarian cancer. Experimental Design: Ninety…”
    Get full text
    Journal Article
  11. 11

    Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan) by Giovanella, Beppino C, Stehlin, John S, Hinz, Hellmuth R, Kozielski, Anthony J, Harris, Nicholas J, Vardeman, Dana M

    Published in International journal of oncology (01-01-2002)
    “…The purpose of this study is to establish the maximum tolerated dose of rubitecan in mice, dogs and men and to establish the anticancer activity of such dose…”
    Get more information
    Journal Article
  12. 12

    DNA Topoisomerase I-Targeted Chemotherapy of Human Colon Cancer in Xenografts by Giovanella, Beppino C., Stehlin, John S., Wall, Monroe E., Wani, Mansukh C., Nicholas, Allan W., Liu, Leroy F., Silber, Robert, Potmesil, Milan

    “…Drug development is needed to improve chemotherapy of patients with locally advanced or metastatic colon carcinoma, who otherwise have an unfavorable…”
    Get full text
    Journal Article
  13. 13

    Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin by GIOVANELLA, B. C, HINZ, H. R, KOZIELSKI, A. J, STEHLIN, J. S, SILBER, R, POTMESIL, M

    Published in Cancer research (Chicago, Ill.) (01-06-1991)
    “…20-(S)-Camptothecin (CAM), a plant alkaloid, was tested against 13 human cancer xenograft lines carried by immunodeficient (nude) mice. The drug, formulated in…”
    Get full text
    Journal Article
  14. 14

    A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor by Verschraegen, C F, Natelson, E A, Giovanella, B C, Kavanagh, J J, Kudelka, A P, Freedman, R S, Edwards, C L, Ende, K, Stehlin, J S

    Published in Anti-cancer drugs (01-01-1998)
    “…9-Nitrocamptothecin (9NC) is a water-insoluble topoisomerase I inhibitor with a broad antitumor activity in animal models. To determine the maximum tolerated…”
    Get more information
    Journal Article
  15. 15

    A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer by Verschraegen, C F, Gupta, E, Loyer, E, Kavanagh, J J, Kudelka, A P, Freedman, R S, Edwards, C L, Harris, N, Steger, M, Steltz, V, Giovanella, B C, Stehlin, J S

    Published in Anti-cancer drugs (01-04-1999)
    “…9-Nitrocamptothecin (9-NC) is a water-insoluble topoisomerase I inhibitor with a broad antitumor activity in animal models. A phase II study was performed in…”
    Get more information
    Journal Article
  16. 16

    Pharmacokinetics of the in vivo and in vitro conversion of 9-nitro-20(S)-camptothecin to 9-amino-20(S)-camptothecin in humans, dogs, and mice by HINZ, H. R, HARRIS, N. J, NATELSON, E. A, GIOVANELLA, B. C

    Published in Cancer research (Chicago, Ill.) (15-06-1994)
    “…We have determined that 9-nitro-20(S)-camptothecin (9NC) converts to 9-amino-20(S)-camptothecin (9AC) in humans, dogs, and mice. Following a single oral dose…”
    Get full text
    Journal Article
  17. 17

    Complete inhibition of growth followed by death of human malignant melanoma cells In vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins by PANTAZIS, P, HINZ, H. R, MENDOZA, J. T, KOZIELSKI, A. J, WILLIAMS, L. J, STEHLIN, J. S, GIOVANELLA, C

    Published in Cancer research (Chicago, Ill.) (15-07-1992)
    “…The plant alkaloid camptothecin and three camptothecin derivatives were used to study responses of human malignant melanoma (BRO) cells xenografted in…”
    Get full text
    Journal Article
  18. 18

    Abstract 4337: In vitro biotransformation of and inhibitory effects of CZ48 in human liver microsomes by Liu, Xing, DeJesus, Albert, Vardeman, Dana, Cao, Zhisong, Giovanella, Beppino

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…BACKGROUND AND PURPOSE CZ48 is a novel potent anticancer agent currently in a phase I clinical trial. The absorption of CZ48 in humans is approximately less…”
    Get full text
    Journal Article
  19. 19

    Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro by PANTAZIS, P, EARLY, J. A, MENDOZA, J. T, DEJESUS, A. R, GIOVANELLA, B. C

    Published in Cancer research (Chicago, Ill.) (01-02-1994)
    “…In a recent study, we showed that the plant alkaloid camptothecin (CPT) and its derivatives 9-nitro-CPT (9NC) and 9-amino-CPT (9AC) inhibit growth of both…”
    Get full text
    Journal Article
  20. 20

    Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models by POTMESIL, M, VARDEMAN, D, KOZIELSKI, A. J, MENDOZA, J, STEHLIN, J. S, GIOVANELLA, B. C

    Published in Cancer research (Chicago, Ill.) (01-12-1995)
    “…Several metastatic models have been developed using clonal selection of human malignant cells metastasizing into a specific organ in NIH-I Swiss…”
    Get full text
    Journal Article